Supported by the Little Princess Trust, the new professorship has been established to harness Oxford's world-leading cancer research capabilities and focus them on one of medicine's most urgent challenges: improving outcomes for children and young people diagnosed with cancer.
While survival rates for many childhood cancers have improved significantly over recent decades, some cancers remain difficult to treat and many children experience lifelong side effects from existing therapies. The new professorship will strengthen efforts to develop more effective, targeted and less toxic treatments for young patients.
Professor Cortés-Ciriano joins Oxford as an internationally recognised scientist with extensive experience in childhood cancer research from EMBL’s European Bioinformatics Institute. He will lead a new research programme within the Department of Paediatrics, bringing together expertise from across the University's extensive cancer research community.
Read the full story on the Department of Paediatrics website